Biofourmis Collaborates with ImagineMIC to Improve Remote Patient Monitoring for Chronic Disease Patients

Biofourmis ImagineMIC Partnership
Image: Biofourmis

Biofourmis, a fast-growing global health IT start-up founded in Singapore, and ImagineMIC, a New York-based medical device company formed a partnership to drive improved outcomes and lower healthcare costs for patients with chronic conditions. ImagineMIC provides chronic care management through remote monitoring services and HIPAA-compliant technology.

Read More Biofourmis to Partner with Yale University-Mayo Clinic Collaborative Program CERSI

The first phase of the collaboration includes integrating Biofourmis’ artificial intelligence (AI)-powered, FDA-cleared RhythmAnalytics with ImagineMIC’s remote management technology, which is monitored by clinicians located in the ImagineMIC Monitoring Intervention Center (MIC) in New York State. RhythmAnalytics, part of Biofourmis’ Biovitals Platform, uses enhanced deep learning architecture to detect dozens of cardiac arrhythmias, says a press release.

RhythmAnalytics will provide clinical decision support for the board-certified emergency physicians, physician assistants, nurse practitioners and specialty-trained registered nurses in the MIC who perform around-the-clock monitoring of thousands of patients with chronic conditions who are in skilled nursing facilities (SNFs) and subacute care programs.

“This is a scalable partnership that is starting with cardiology, which could ultimately be applied to a number of chronic conditions and therapeutic areas in various care settings by leveraging various modules within the Biovitals Platform for those applications,” said Kuldeep Singh Rajput, CEO of Biofourmis.

A computer monitor
Image: ImagineMIC

ImagineMIC’s wearables provide real-time data on patients’ respiratory rate, oxygen levels and heart rate; and Bluetooth streams report blood pressure, blood glucose and weight.

RhythmAnalytics will support ImagineMIC’s clinicians by alerting them to more than 20 types of cardiac arrhythmias, along with beat-by-beat morphology computation that includes ventricular arrhythmias, ventricular ectopic beats and all non-paced arrhythmias, including atrial fibrillation (AFib). Biofourmis’ RhythmAnalytics were trained using over 4 million electrocardiogram (ECG) recordings collected from patients using various FDA-cleared ECG monitoring wearables.

Read more Biofourmis Buys Biovotion to Deliver Precise Interventions for Patients with Complex Chronic Conditions

“Improving cardiac outcomes and reducing care costs for the ‘silver tsunami’ of seniors in the healthcare system will require a new paradigm of chronic care management that includes 24-hour chronic care management supported with proven, revolutionary technology,” said Anthony J. Bacchi, MD, CEO and founder of ImagineMIC. “This collaboration is extremely synergistic, since Biofourmis’ RhythmAnalytics and Biovitals Platform also have been demonstrated to deliver extraordinary results that reduce costs and improve patient outcomes.”